As a pioneer in antibody-drug conjugates (ADCs), Seagen has led the way in novel cancer therapeutics for more than 25 years. They’re committed to discovering safe and effective solutions to challenging clinical needs. Their research efforts are dedicated to advancing a pipeline of innovative therapies for solid tumors and blood-related cancers.
Graphica has been working with Seagen since 2012. During this time, we have helped to evolve their corporate brand as their company grew and their products moved through the development pipeline. When the company changed their name from Seattle Genetics to Seagen, we refined the company logo and developed the core brand elements that are in use today. We continue to provide a wide range of services that include external, internal, and investor communications as well as special events. The projects featured below represent a small sampling of the work we have produced for this inspirational company.
Clinical Trials Collateral
Investor Relations Materials